Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP-HTM) Competitive Revisions (U19)
Purpose.
The purpose of this Funding Opportunity Announcement (FOA) is to notify NIAID Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP-HTM) U19 grantees of the opportunity to expand the scope of their current IPCP-HTM award.
The IPCP-HTM program supports multi-project, multi-disciplinary preclinical and exploratory clinical studies to advance safe, effective and acceptable novel topical microbicides and microbicide combination strategies for the prevention of HIV.
Competitive revisions may be used to address gaps or opportunities in funded IPCP-HTM programs.
Applicants propose to expand the scope of a current IPCP-HTM award Mechanism of Support.
This Competitive Revision FOA will utilize the multi-project Cooperative Agreement (U19) award mechanism.
A FOA of identical scientific scope, RFA-AI-10-006, for new IPCP-HTM awards is being published closely with this FOA.
Funds Available and Anticipated Number of Awards.
NIAID and NIMH anticipate making awards for a total of $6 million in FY 2011 for the combination of the Competitive Revision IPCP-HTM applications under this FOA and applications to RFA-AI-10-006, IPCP-HTM FOA.
At least 1 award is anticipated.
The purpose of this Funding Opportunity Announcement (FOA) is to notify NIAID Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP-HTM) U19 grantees of the opportunity to expand the scope of their current IPCP-HTM award.
The IPCP-HTM program supports multi-project, multi-disciplinary preclinical and exploratory clinical studies to advance safe, effective and acceptable novel topical microbicides and microbicide combination strategies for the prevention of HIV.
Competitive revisions may be used to address gaps or opportunities in funded IPCP-HTM programs.
Applicants propose to expand the scope of a current IPCP-HTM award Mechanism of Support.
This Competitive Revision FOA will utilize the multi-project Cooperative Agreement (U19) award mechanism.
A FOA of identical scientific scope, RFA-AI-10-006, for new IPCP-HTM awards is being published closely with this FOA.
Funds Available and Anticipated Number of Awards.
NIAID and NIMH anticipate making awards for a total of $6 million in FY 2011 for the combination of the Competitive Revision IPCP-HTM applications under this FOA and applications to RFA-AI-10-006, IPCP-HTM FOA.
At least 1 award is anticipated.
Related ProgramsDepartment of Health and Human Services
Allergy, Immunology and Transplantation Research
Department of Health and Human ServicesMicrobiology and Infectious Diseases Research
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $6,000,000
Office: National Institutes of Health
Estimated Funding: $6,000,000
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-10-007.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Eligible institutions are current NIAID IPCP-HTM awardees.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-10-007.html
Contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
FBOWebmaster@OD.NIH.GOV
Date Posted:
2010-08-02
Application Due Date:
2010-11-17
Archive Date:
2010-12-18
Social Entrepreneurship
Spotlight
The U.S. Government on Cultivating Impact Investing And Social Enterprise
According to a Private Capital, Public Good report recently released at the White House from a group of A-list impact investing and social enterprise specialists, the U.S. government can do a lot to spur the growth among the impact investing and social enterprise sectors.
Learn How to Identify and Avoid Grant Scams
